BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.42B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$704M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$517M |
| 5 |
Nike
NKE
|
+$489M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$283M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$156M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$72M |
| 5 |
NVIDIA
NVDA
|
+$68.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.16% |
| 2 | Consumer Discretionary | 6.92% |
| 3 | Financials | 5.71% |
| 4 | Healthcare | 5.18% |
| 5 | Communication Services | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
CALL
Emerson Electric
EMR
$91.6B
| $4.43M | 0.01% |
452
-559
| -55% | -$52.9K |
|
1252
Jabil
JBL
$38.8B
| $4.43M | 0.01% |
71,755
+8,678
| +14% | +$535K |
|
1253
CALL
Colgate-Palmolive
CL
$74.1B
| $4.42M | 0.01% |
583
+433
| +289% | +$34.3K |
|
1254
Newell Brands
NWL
$2.63B
| $4.41M | 0.01% |
205,872
+42,977
| +26% | +$993K |
|
1255
Beyond Meat
BYND
$6.3B
| $4.41M | 0.01% |
3,040
+2,101
| +224% | +$3.46M |
|
|
ABMD
1256
DELISTED
Abiomed Inc
ABMD
| $4.4M | 0.01% |
13,286
-12,240
| -48% | -$3.77M |
|
1257
W.P. Carey
WPC
$16.3B
| $4.4M | 0.01% |
55,578
-36,059
| -39% | -$2.77M |
|
1258
iShares MSCI Turkey ETF
TUR
$220M
| $4.39M | 0.01% |
212,248
+50,429
| +31% | +$993K |
|
1259
PUT
S&P Global
SPGI
$125B
| $4.39M | 0.01% |
107
-1,305
| -92% | -$532K |
|
1260
Schneider National
SNDR
$6.27B
| $4.36M | 0.01% |
171,036
+25,168
| +17% | +$655K |
|
|
SCHW
1261
CALL
Charles Schwab
SCHW
$190B
| $4.36M | 0.01% |
517
-277
| -35% | -$24.4K |
|
1262
Intellia Therapeutics
NTLA
$1.66B
| $4.36M | 0.01% |
59,941
+22,983
| +62% | +$1.95M |
|
|
EA
1263
PUT
DELISTED
Electronic Arts
EA
| $4.35M | 0.01% |
344
-729
| -68% | -$94.9K |
|
1264
KBR
KBR
$4.81B
| $4.34M | 0.01% |
79,318
+20,431
| +35% | +$993K |
|
1265
Teledyne Technologies
TDY
$31.2B
| $4.34M | 0.01% |
9,175
+1,873
| +26% | +$806K |
|
1266
Jefferies Financial Group
JEF
$12.9B
| $4.32M | 0.01% |
137,419
-16,614
| -11% | -$564K |
|
|
NVMI
1267
Nova
NVMI
$13.1B
| $4.31M | 0.01% |
39,573
+2,552
| +7% | +$298K |
|
1268
Comstock Resources
CRK
$3.99B
| $4.28M | 0.01% |
328,021
-298,817
| -48% | -$2.66M |
|
1269
JPMorgan Ultra-Short Income ETF
JPST
$40.6B
| $4.28M | 0.01% |
85,133
+9,658
| +13% | +$486K |
|
1270
Lithia Motors
LAD
$8.32B
| $4.28M | 0.01% |
14,250
-3,215
| -18% | -$1M |
|
|
SEM
1271
DELISTED
Select Medical
SEM
| $4.27M | 0.01% |
330,078
+2,214
| +0.7% | +$29.2K |
|
1272
Darling Ingredients
DAR
$10.4B
| $4.27M | 0.01% |
53,068
+6,579
| +14% | +$458K |
|
1273
PUT
Jazz Pharmaceuticals
JAZZ
$16B
| $4.27M | 0.01% |
274
+172
| +169% | +$25K |
|
1274
PUT
iShares MSCI Germany ETF
EWG
$1.67B
| $4.26M | 0.01% |
+1,500
| New | +$45.7K |
|
1275
HUTCHMED
HCM
$2.13B
| $4.25M | 0.01% |
224,792
-5,766
| -3% | -$147K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2022 Portfolio in Review
As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.
- BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
- BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
- BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
- BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
- BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.